To the best of our knowledge, four variants have been reported in XPO5, of which only one homozygous variant has been identified in a boy with kidney disease and the other three variants have been found in patients with Wilms tumor, autism, and multiple myeloma. This evidence concerns the gene XPO5 and AL amyloidosis.